Specifically, non-IgE-mediated asthma, often associated with LMW agents, significantly impacted recurrence rates, increasing the likelihood approximately ninefold (odds ratio 8.7 (95% CI, 2-46); p < 0.012). Here, IGHE is linked to asthma.